Enterprise Value to EBITDA Multiple ratio Analysis of Biofil Chemicals & Pharmaceuticals Ltd. - Deep Dive
Birds's Eye
Fundamentals
Fundamentals
Technicals
MovingAverage
Candlestick
PivotPoint
Beta&Vols
Tech ChartsEnterprise Value to EBITDA Multiple of BIOFILCHEM
Mar-2569.10Very Poor EV to EBITDA | Mar-2473.24Very Poor EV to EBITDA | Growth-5.65% |
EV to EBITDA Analysis of Biofil Chemicals & Pharmaceuticals Ltd.
| Enterprise Value to EBITDA of Biofil Chemicals & Pharmaceuticals Ltd. with value of 69.10 implies that the company is overvalued. |
| EV to EBITDA Ratio of BIOFILCHEM has fallen by -5.65 % Compared to previous Financial Year. |
| EV to EBITDA Ratio with value of 73.24 was highest in Year Mar-24 in last Five Years. |
| EV to EBITDA Ratio with value of 44.65 was lowest in Year Mar-21 in last Five Years. |
| Latest EV to EBITDA Ratio with value of 69.10 is Greater than Average EV to EBITDA of 62.89 in last five years. |
Other EV to EBITDA Related Info of BIOFILCHEM that may interest you.
Biofil Chemicals & Pharmaceuticals Ltd. Overview
| Code | Price | Previous Price | Price Change | Sector |
|---|---|---|---|---|
| BIOFILCHEM | 39.74 | 38.58 | 3.01 % | Drugs & Pharma |
Defination of Enterprise Value to EBITDA Multiple
Enterprise Value-to-EBITDA Ratio is used to compare a company's Enterprise Value to its EBITDA (Earnings before Interest, Taxes, Depreciation, and Amortization). It is useful to determine the value of a company, whether it is undervalued or overvalued. more ..
EV to EBITDA Related Ratios
| EBITDAMargin | EVToRevenue | PriceToEarningRatio |
Tsr Value Index
| Poor Value Stock | Screener |
FY - Historical Enterprise Value to EBITDA Multiple of Biofil Chemicals & Pharmaceuticals Ltd.
| Period | Mar-25 | Mar-24 | Mar-23 | Mar-22 | Mar-21 | Mar-20 | Mar-19 |
|---|---|---|---|---|---|---|---|
| EV to EBITDA | 69.10 | 73.24 | 63.84 | 63.65 | 44.65 | 5.92 | 11.40 |
| Change | -5.65 % | 14.72 % | 0.306 % | 42.56 % | 654.75 % | -48.11 % | -50.25 % |
| Price | 41.16 | 60.60 | 41.40 | 57.65 | 65.85 | 7.50 | 6.95 |
| Price Change | -32.08 % | 46.38 % | -28.19 % | -12.45 % | 778.00 % | 7.91 % | -49.82 % |
FY Chart of Enterprise Value to EBITDA Multiple of Biofil Chemicals & Pharmaceuticals Ltd.
Value Investing eBook
Free PDF eBook on Value Investing
Value Investing eBook
Free PDF eBook on Value Investing